In Vitro Evaluation of Alpha-Amylase Inhibitory Activity of Ethanolic Leaf Extracts of Aegle marmelos and Turnera ulmifolia
DOI:
https://doi.org/10.22376/ijlpr.v15i2.1993Keywords:
Aegle marmelos, Turnera ulmifolia, Alpha-amylase inhibition, Postprandial hyperglycemia, Plant-based enzyme inhibitorsAbstract
Aegle marmelos (Bael), a medicinal plant widely used in traditional Ayurvedic medicine, has shown promising antidiabetic, antioxidant, and hepatoprotective effects. Their leaves contain many bioactive constituents such as flavonoids, tannins, alkaloids, and coumarins, contributing to their therapeutic potential. Similarly, Turnera ulmifolia, commonly known as yellow alder, is an ethnomedicinal plant exhibiting antihyperglycemic, antioxidant, and anti-inflammatory activities. This study investigates the in vitro α-amylase inhibitory potential of ethanolic leaf extracts of Aegle marmelos and Turnera ulmifolia. The extracts were prepared by cold maceration and assessed using the DNS assay. Among the tested samples, Aegle marmelos demonstrated notable inhibitory activity, while Turnera ulmifolia showed minimal effect. These findings support the traditional use of Aegle marmelos in diabetes management and highlight the need for further studies to isolate active constituents and evaluate their in vivo efficacy.
References
American Diabetes Association. Standards of medical care in diabetes—2023. Diabetes Care. 2023;46(Suppl 1):S1–S290.
Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045. Diabetes Res Clin Pract. 2019;157:107843.
International Diabetes Federation. IDF Diabetes Atlas, 10th edition. Brussels, Belgium: International Diabetes Federation; 2021.
Ali H, Houghton PJ, Soumyanath A. α-Amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus. J Ethnopharmacol. 2006;107(3):449-455.
Sales PM, Souza PM, Simeoni LA, Silveira D. α-Amylase inhibitors: a review of raw material and isolated compounds from plant source. J Pharm Pharm Sci. 2012;15(1):141–183.
Van de Laar FA, Lucassen PL, Akkermans RP, et al. α-Glucosidase inhibitors for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005;(2): CD003639.
Balasubramaniam A, Pandian MR, Suresh B. Pharmacological activities of Aegle marmelos: a review. Int J Pharm Sci Rev Res. 2011;6(2):24-29.
Ponnusamy S, Ravindran R, Zinjarde SS, Bhargava SY, Kumar AR. Evaluation of traditional Indian antidiabetic medicinal plants for α-amylase inhibition. Evid Based Complement Alternat Med. 2011;2011:515647.
Harborne JB. Phytochemical methods: A guide to modern techniques of plant analysis. 3rd ed. London: Chapman & Hall; 1998.
Kokate CK. Practical Pharmacognosy. 4th ed. Delhi: Vallabh Prakashan; 2010.
Azwanida NN. A review of the extraction methods used in medicinal plants, principles, strengths, and limitations. Med Aromat Plants. 2015;4(3):196.
Bimakr M, Rahman RA, Taip FS, Adzahan NM, Sarker MZ. Supercritical carbon dioxide extraction of bioactive flavonoid compounds from Spearmint (Mentha spicata L.) leaves. Food Bioprod Process. 2011;89(1):67–72.
Lebovitz HE. Alpha-glucosidase inhibitors. Endocrinol Metab Clin North Am. 1997;26(3):539–551.
Van de Laar FA, Lucassen PL, Akkermans RP, et al. Alpha-glucosidase inhibitors for patients with type 2 diabetes: a systematic review. Cochrane Database Syst Rev. 2005;(2): CD003639.
Sabu MC, Kuttan R. Antidiabetic activity of Aegle marmelos and its relationship with its antioxidant properties. Indian J Physiol Pharmacol. 2004;48(4):514–520.
Rani S, Rani S, Khullar N, Arora S. A review on Aegle marmelos: phytochemistry and pharmacological activities. J Drug Deliv Ther. 2018;8(6):91–96.
Ponnusamy S, Ravindran R, Zinjarde SS, Bhargava SY, Kumar AR. Evaluation of antidiabetic activity of Turnera ulmifolia. Evid Based Complement Alternat Med. 2011;2011:515647.
Wagner H, Ulrich-Merzenich G. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine. 2009;16(2-3):97–110.
Williamson EM. Synergy and other interactions in phytomedicines. Phytomedicine. 2001;8(5):401–409.
Trease GE, Evans WC. Pharmacognosy. 16th ed. London: Elsevier Health Sciences; 2009.
Sofowora A. Medicinal Plants and Traditional Medicine in Africa. 2nd ed. Ibadan: Spectrum Books Ltd; 1993.
Bernfeld P. Amylases, α and β. In: Colowick SP, Kaplan NO, editors. Methods in Enzymology. Vol. 1. New York: Academic Press; 1955. p. 149–158.
Ademiluyi AO, Oboh G. Soybean phenolic-rich extracts inhibit key enzymes linked to type 2 diabetes (α-amylase and α-glucosidase) and hypertension (angiotensin I converting enzyme) in vitro. Exp Toxicol Pathol. 2013;65(3):305–309.
Kim YM, Jeong YK, Wang MH, Lee WY, Rhee HI. Inhibitory effect of pine extract on alpha-glucosidase activity and postprandial hyperglycemia. Nutrition. 2005;21(6):756–761.
Shivaprakash G, Pai MRS, Nandini M, Reshma K, Sahana DA, Rajendran K, Shirwaikar A, Adhikari Prabha MR, Ganesh J. Antioxidant Potential Of Eugenia jambolana Seed; A Randomized Clinical Trial In Type 2 Diabetes Mellitus. Int J Pharm Bio Sci. 2011 Apr-Jun;2(2):220–8.
Mathew R, Pai VR, Vijayakumar T. Comparative evaluation of conventional and new biomarkers of renal involvement in patients with type 2 diabetes mellitus and hypertension – a pilot study. Int J Pharm Bio Sci. 2013 Apr-Jun;4(2):742–750.
R. R. Rakhee Raj, S. S. Sanjay Sahay, and J. T. Jagriti Tripathi, “Medications of diabetes mellitus and antidiabetic medicinal plants: A review”, Int J Indig Herb Drug, pp. 19-28, Dec. 2016.
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
